The expression of the receptor for advanced glycation end products (RAGE) is increased in the brain endothelium of AD patients, whereas the expression of low-density lipoprotein receptor-related protein 1 (LRP1) is reduced [35]. This evidence concerns the gene LRP1 and Alzheimer disease.